PharmaEssentia Corporation (TPE:6446)
512.00
-6.00 (-1.16%)
At close: Jan 9, 2026
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 189.36 billion as of January 9, 2026. Its market cap has decreased by -4.14% in one year.
Market Cap
189.36B
Enterprise Value
168.67B
Revenue
13.82B
Ranking
n/a
PE Ratio
39.54
Stock Price
512.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 189.36B, an increase of 380.81%. That is a compound annual growth rate of 14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 191.58B | 10.21% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 234.05B |
| Lotus Pharmaceutical | 71.53B |
| Heron Neutron Medical | 61.27B |
| Bora Pharmaceuticals Co., LTD. | 59.28B |
| Lin BioScience | 32.14B |
| Lumosa Therapeutics | 30.83B |
| Center Laboratories | 29.97B |
| Oneness Biotech | 27.94B |